These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 12434738

  • 1. Topical [symbol: see text] tacrolimus--a role in atopic dermatitis?
    Drug Ther Bull; 2002 Oct; 40(10):73-5. PubMed ID: 12434738
    [Abstract] [Full Text] [Related]

  • 2. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A, Allen BR, Reitamo S.
    J Dermatolog Treat; 2003 Oct; 14(Suppl 1):5-16. PubMed ID: 14522634
    [Abstract] [Full Text] [Related]

  • 3. Topical tacrolimus: a new therapy for atopic dermatitis.
    Russell JJ.
    Am Fam Physician; 2002 Nov 15; 66(10):1899-902. PubMed ID: 12469964
    [Abstract] [Full Text] [Related]

  • 4. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Ned Tijdschr Geneeskd; 2005 May 14; 149(20):1096-100. PubMed ID: 15932135
    [Abstract] [Full Text] [Related]

  • 5. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis.
    Br J Dermatol; 2004 Dec 14; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [Abstract] [Full Text] [Related]

  • 6. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
    Ruzicka T, Bieber T, Schöpf E, Rubins A, Dobozy A, Bos JD, Jablonska S, Ahmed I, Thestrup-Pedersen K, Daniel F, Finzi A, Reitamo S.
    N Engl J Med; 1997 Sep 18; 337(12):816-21. PubMed ID: 9295241
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun 18; 13(71):86-9. PubMed ID: 15233141
    [Abstract] [Full Text] [Related]

  • 8. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N, Reitamo S, Dubertret L, Fekete GL, Kamoun MR, Lahfa M, Ortonne JP.
    Br J Dermatol; 2009 Aug 18; 161(2):427-34. PubMed ID: 19416227
    [Abstract] [Full Text] [Related]

  • 9. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP, Curran MP.
    Am J Clin Dermatol; 2010 Aug 18; 11(4):295-8. PubMed ID: 20509720
    [Abstract] [Full Text] [Related]

  • 10. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, US Tacrolimus Ointment Study Group.
    Pediatrics; 2008 Dec 18; 122(6):e1210-8. PubMed ID: 19015204
    [Abstract] [Full Text] [Related]

  • 11. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA, Moloney FJ, Ahmadi S, Stevenson P, Murphy GM.
    Br J Dermatol; 2009 Mar 18; 160(3):665-9. PubMed ID: 19076975
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC, Fleisher AB.
    Skin Therapy Lett; 2004 Nov 18; 9(9):1-5. PubMed ID: 15550992
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R.
    J Med Assoc Thai; 2006 Nov 18; 89(11):1915-22. PubMed ID: 17205874
    [Abstract] [Full Text] [Related]

  • 14. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S, Ortonne JP, Sand C, Cambazard F, Bieber T, Fölster-Holst R, Vena G, Bos JD, Fabbri P, Groenhoej Larsen C, European Tacrolimus Ointment Study Group.
    Br J Dermatol; 2005 Jun 18; 152(6):1282-9. PubMed ID: 15948994
    [Abstract] [Full Text] [Related]

  • 15. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, Smith C, Moss C, Dobozy A, Palatsi R, European Tacrolimus Ointment Group.
    Br J Dermatol; 2004 Mar 18; 150(3):554-62. PubMed ID: 15030341
    [Abstract] [Full Text] [Related]

  • 16. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR.
    Ned Tijdschr Geneeskd; 2005 Aug 06; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract] [Full Text] [Related]

  • 17. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec 06; 13(74):209-12. PubMed ID: 15599989
    [Abstract] [Full Text] [Related]

  • 18. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A, Harper J, Rustin M, Goldschmidt WF, Palatsi R, van der Valk PG, Sharpe G, Smith CH, Dobozy A, Turjanmaa K, European Tacrolimus Ointment Study Group.
    Acta Derm Venereol; 2007 Dec 06; 87(1):54-61. PubMed ID: 17225017
    [Abstract] [Full Text] [Related]

  • 19. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.
    Rustin MH.
    Br J Dermatol; 2007 Nov 06; 157(5):861-73. PubMed ID: 17854353
    [Abstract] [Full Text] [Related]

  • 20. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
    Patel RR, Vander Straten MR, Korman NJ.
    Arch Dermatol; 2003 Sep 06; 139(9):1184-6. PubMed ID: 12975161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.